Joseph Dedvukaj
Contributor since: 2012
Company: Independent Investor
Latest Articles
Arena's APD371 For $14 Billion Pain Market
Arena: Star Acquisition Target Post Positive Trial Results
Assessing Chances Of Success For Arena Pharmaceutical's Highly Anticipated Etrasimod P2 Results
Arena Pharmaceuticals: Significance Of This Quarter's Catalysts
Time To Take A Full Position In QuickLogic Stock, As Production Wins Grow To 9 Consumer Products
Arena Pharma Races Toward Q1 2018 Trial Results
Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy?
QuickLogic Reveals OEM Engagements, Developer Tools To Accelerate Advanced Sensor Processor Sales
Arena's Smoking Cessation, Nash, Combination Belviq-Phentermine, Free Belviq Samples
QuickLogic Sampling The Most Advanced Sensor Hub Produced To Date
Why Investors Should Accumulate Shares Of Quicklogic
Direct-To-Consumer Television Advertising Marks The Tipping Point For Belviq Sales
QuickLogic Is Another Way To Ride The Coming Wave Of Always-On-Context-Aware Devices
How Will QuickLogic Benefit From The Coming Paradigm Shift In Mobile Computing?
What Do Analyst Upgrades And Coverage Mean For QuickLogic?
Will QuickLogic Break Out Further?
QuickLogic Wins 3 New Production Orders Despite Revenue Miss
Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales
QuickLogic Has The Ingredients For Success In 2013
Towerstream Corporation Is On The Verge Of Explosive Profits
Arena Pharmaceuticals Outlines Its Path To Profitability
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
Paramount Gold & Silver Corporation - The Ultimate Miner's Bliss:
QuickLogic - The Next High-Tech Growth Stock